BridgeMD
New treatment option for Breast Cancer
Official title ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
ClinicalTrials.gov ID: NCT06085833
What this study is testing
- What it's testing
- This prospective, blinded, single-arm study aims to test the performance of nanomechanical phenotype in predicting tumor type, tumor aggressiveness, and neoadjuvant treatment response compared to the gold standard of histopathological assessment. The study involves patients with suspicious breast lesions who will undergo a breast biopsy procedure indicated by standard of care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged ≥ 18 years
- Ability to understand and the willingness to sign a written informed consent.
- Indication for breast biopsy for diagnostic purposes
- ECOG performance status of 0 to 3.
You likely can't join if
- Conditions that, in the investigator's opinion, might indicate that the subject is not suitable for the study.
The study team makes the final eligibility decision.
Where it's taking place
- Dallas, Texas, United States
- Houston, Texas, United States
- Barcelona, Barcelona, Spain
- Basel, Basel, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dallas, Texas, United States; Houston, Texas, United States; Barcelona, Barcelona, Spain; Basel, Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.